News & HighlightsNews
Early intervention with new treatment provides durable control of HIV-like virus in monkeys
There are more than 25 drugs to control HIV, yet the virus remains one of the world’s biggest health problems. One of the many challenges with existing therapies is that a dormant version of the virus is always lurking in the background, ready to attack the immune system as soon as treatment is i...
Study tests the “three-hit” theory of autism
Since the first case was documented in the United States in 1938, the causes of autism have remained elusive. Hundreds of genes, as well as environmental exposures, have been implicated in these brain disorders. Sex also seems to have something to do with it: About 80 percent of children diagnose...
A new way to reset gene expression in cancer cells shows promise for leukemia treatment
New findings from Rockefeller University researchers could guide the development of potent combination therapies that deliver more effective and durable treatment of leukemia. In recent work published in Nature, they show it’s possible to deactivate cellular programs involved in tumor growth by d...
Raphael Cohn wins 2017 Weintraub Graduate Student Award
Raphael Cohn, a graduate fellow in Vanessa Ruta’s Laboratory of Neurophysiology and Behavior, is a recipient of this year’s Harold M. Weintraub Graduate Student Award, one of the country’s most prestigious graduate student prizes in the biosciences. The award, given by the Fred Hutchinson Canc...
New structural studies reveal workings of a molecular pump that ejects cancer drugs
Sometimes cells resist medication by spitting it back out. Cancer cells, in particular, have a reputation for defiantly expelling the chemotherapy drugs meant to kill them. Researchers at The Rockefeller University have shed new light on a molecular pump that makes this possible, by determining i...
New research explains why a common bacterium can produce severe illness
As much as we try to avoid it, ­we are constantly sharing germs with those around us. But even when two people have the same infection, the resulting illnesses can be dramatically different—mild for one person, severe or even life-threatening for the other. Now, new research from The Rockefell...
Jeffrey V. Ravetch receives 2017 Ross Prize in Molecular Medicine
Jeffrey V. Ravetch, Theresa and Eugene M. Lang Professor and head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology, has won the 2017 Ross Prize in Molecular Medicine. The award, given by The Feinstein Institute for Medical Research and its journal Molecular Medicine, honors s...
Crowdsourcing effort helps researchers predict how a molecule will smell
You can anticipate a color before you see it, based solely on the length of light waves. Music can be interpreted from notes on a page without being heard. Not so with odor.
Mouse studies offer new insights about cocaine’s effect on the brain
 Cocaine is one of the most addictive substances known to man, and for good reason: By acting on levels of the “feel-good” chemical dopamine, it produces a tremendous sensation of euphoria. Now the laboratory of Rockefeller University Professor and Nobel Laureate Paul Greengard has shown...
Newly discovered beetle species named after Rockefeller’s Daniel Kronauer
 Scientists can rack up many awards, but to have one’s name cemented in scientific nomenclature is a special kind of honor. In an homage to his mentor Daniel Kronauer, former Rockefeller postdoctoral associate Christoph von Beeren has named a new species of beetle Nymphister kronaueri. ...
View
View